中文 | English
Return
Total: 55 , 1/6
Show Home Prev Next End page: GO
Author:( Hongxing YU)

1.Research progress of imaging evaluation methods for curative effect of chemoradiotherapy in esophageal cancer

Zhihong YU ; Hongxing JIN

Cancer Research and Clinic 2015;(7):499-501

2.Effects of Matrine on STAT1, STAT3, CTGF, PDGF expression in fetal glomerular mesangial cells under lipopolysaccharide

Jie SU ; Yu JIN ; Hongxing DANG ; Jizu LING

Journal of Clinical Pediatrics 2010;(2):178-182

4.International experience on the division and cooperation among medical institutions and its implications for China:An analysis of the UK, Germany, Singapore and the US

Hongxing YU ; Youmei FENG ; Min FU ; Zhiyong LIU ; Lan YAO

Chinese Journal of Health Policy 2014;(6):10-15

5.Application of immunophenotypes in pathologic diagnosis of follicular lymphomas

Tong ZHU ; Baxiong WEI ; Hongxing LIAO ; Yongjie YU

Journal of Leukemia & Lymphoma 2015;24(12):736-739

6.Effects of rTMS on the LZ complexity of EEG signals and distribution of MBP in AD rats

Guixue CUI ; Hailiang YAN ; Yi YU ; Hongxing ZHANG

The Journal of Practical Medicine 2017;33(15):2468-2473

7.Clinical Significance of Serum IL-10 and IL-17 in Patients with Systemic Lupus Erythematosus

Yijun YANG ; Jiangang DU ; Qinfang ZHU ; Qian YU ; Hongxing XU

Journal of Modern Laboratory Medicine 2017;32(3):71-73,78

8.Oxymatrine suppresses p-STAT1/PIAS1 signaling in LPS-induced human mesangial cells proliferation

Hongxing DANG ; Yu JIN ; Yuning LI ; Jizu LING ; Jie SU

Journal of Third Military Medical University 2003;0(17):-

9.Brief discussion on "Sanli acupoint for du-fu diseases".

Li ZHOU ; Quan HE ; Yu XIN ; Hongxing ZHANG

Chinese Acupuncture & Moxibustion 2015;35(7):723-726

10.Effect of oxymatrine on the expression of p-STAT3 and PIAS3 in human mesangial cells

Hongxing DANG ; Yu JIN ; Yuning LI ; Jizu LING ; Jie SU

Chinese Journal of Nephrology 2009;25(8):635-639

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 55 , 1/6 Show Home Prev Next End page: GO